Richmond Pharmacology

Exhibitor

Richmond Pharmacology is an early phase clinical trials unit founded in 2001. We are one of fourteen MHRA accredited Phase I units in the UK. Our core competency is the design and conduct of early phase adaptive trials using MHRA endorsed protocol templates. This approach enables us to add value by running entire early phase programs including intensive cardiac assessments, Japanese ethnic bridging, and exploratory assessments in patients within one protocol and one approval. The work we do is well respected globally, acknowledged as world leaders in cardiovascular safety studies and adaptive study designs.

website